TUM – Technical University of Munich Menü

Prof. Dr. Jürgen Gschwend

Professorship

Urology

Academic Career and Research Areas

The research interests of Professor Gschwend (b.1962) focus primarily on operative and clinical urooncology. He carries out research projects on the molecular oncology of the bladder and prostatic carcinoma focusing particularly on micrometastasis and signal transduction.

After completing his medical studies at LMU Munich and the University of Ulm and earning his PhD in 1988, Professor Gschwend continued his clinical training at the University Hospital in Ulm working with Professor Hautmann and at the Memorial Sloan-Kettering Cancer Center in New York. He acquired his postdoctoral teaching qualification (habilitation) in 1998 for his work on apoptosis induction in prostatic carcinoma. Since 2006 he has been a full professor of urology at TUM. Professor Gschwend is also a spokesperson for the Working Group for Urological Oncology of the German Cancer Society (DKG), member of the advisory board of the TUM`s university hospital Rechts der Isar and Vice-Dean of the TUM School of Medicine.

    Awards

    • Lehrpreis der medizinischen Fakultät und der Fachschaft Medizin der TUM (2008)
    • Maximilian Nitze-Preis der Deutschen Gesellschaft für Urologie (2000)
    • Merckle-Forschungspreis der Universität Ulm (2000)

    Key Publications

    Gschwend JE, Heck MM, Lehmann J, Rübben H, Albers P, Wolff JM, Frohneberg D, de Geeter P, Heidenreich A, Kälble T, Stöckle M, Schnöller T, Stenzl, A, Müller M, Truss M, Roth S, Liehr UB, Leißner J, Bregenzer T, Retz M: "Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial". European Urology. 2018. pii: S0302-2838(18)30737-1.

    Abstract

    Heck MM, Retz M, Bandur M, Souchay M, Vitzthum E, Weirich G, Schuster T, Autenrieth M, Kübler H, Maurer T, Thalgott M, Herkommer K, Gschwend JE, Nawroth R: "Molecular lymph node status for prognostic stratification of prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection". Clinical Cancer Research. 2018; 24(10): 2342-2349.

    Abstract

    Eiber M, Maurer T, Souvatzoglou M, Beer AJ, Ruffani A, Haller B, Graner FP, Kübler H, Haberhorn U, Eisenhut M, Wester HJ, Gschwend JE, Schwaiger M: "Evaluation of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy". The Journal of Nuclear Medicine. 2015; 56(5): 668-674.

    Abstract

    Maurer T, Weirich G, Schottelius M, Weineisen M, Frisch B, Okur A, Kübler H, Thalgott M, Navab N, Schwaiger M, Wester HJ, Gschwend JE, Eiber M: "Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer". European Urology. 2015; 68(3): 530-534.

    Abstract

    Heck MM, Retz M, Bandur M, Souchay M, Vitzthum E, Weirich G, Mollenhauer M, Schuster T, Autenrieth M, Kübler H, Maurer T, Thalgott M, Herkommer K, Gschwend JE, Nawroth R: "Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study". European Urology. 2014; 66(2): 222-229.

    Abstract